PDCD1 and non-small cell lung carcinoma: found decreased abundance of Odoribacter, Gordonibacter, Stoquefichus, Escheria-Shigella, and Collinsella genera and increased abundance of Clostridium sensu stricto1 in fecal samples of NSCLC patients receiving anti-PD-1 therapy.